• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超分子构筑基元在开发具有定制物理稳定性的共无定形系统方面的潜力:整合动力学和热力学的机制见解。

The potential of supramolecular synthon to develop coamorphous systems with tailored physical stability: Mechanistic insights integrating kinetics and thermodynamics.

机构信息

School of Pharmacy, China Pharmaceutical University, Nanjing 211198, PR China; School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, PR China.

School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, PR China.

出版信息

Int J Pharm. 2024 Dec 25;667(Pt A):124857. doi: 10.1016/j.ijpharm.2024.124857. Epub 2024 Oct 21.

DOI:10.1016/j.ijpharm.2024.124857
PMID:39442766
Abstract

Coamorphous drug delivery systems have received increasing interest owing to their potential to improve the solubility, dissolution and bioavailability of poorly water-soluble drugs. However, the crystallization risk is one of major limitations in their application. It has been widely recognized that the coformer plays a vital role in physical stability of coamorphous formulation. Unfortunately, the screen of optimal coformer still adopts a trial-and-error method, which is time-consuming and expensive. Herein, a supramolecular synthon approach based on the interaction between functional groups, was exploited to design coamorphous systems (CMs) consisting of lurasidone hydrochloride (LH) and three coformers, saccharin (SAC), L-tryptophan (TRP), and L-cysteine hydrochloride (CYS). X-ray powder diffraction suggested the order of physical stability of the coamorphous systems was ranked as LH-CYS CM > LH-TRP CM > LH-SAC CM. The charge-assisted hydrogen bond between LH and coformer was confirmed by infrared spectroscopy and solid-state C NMR. Moreover, structural, electronic, and molecular interaction information, especially hydrogen bonding interactions, were quantified by theoretical calculations, including miscibility calculations, molecular dynamics simulations and quantum chemical calculations. It was revealed that LH-CYS CM exhibited the best miscibility, strongest binding energy and strongest H-bond with partially covalent character, demonstrating the significant role of supramolecular synthon in stabilizing coamorphous formulations. Interestingly, LH-TRP CM, not LH-CYS CM, exhibited the lowest molecular mobility among three coamorphous systems, which was inconsistent with their physical stability. But from thermodynamic perspective, the order of configurational entropy and physical stability of coamorphous systems was completely consistent. We shed light on the comprehensive effects of molecular mobility and configurational entropy on physical stability of coamorphous systems. Importantly, the relationship between supramolecular synthon and kinetic/thermodynamic mechanisms was also discussed, and the positive correlation between configurational entropy and intermolecular interactions was proposed in this paper. Our findings demonstrated the great potential of supramolecular synthon in designing coamorphous systems with tailored physical stability, and further provided a deeper insight into the mechanisms of physical stability of coamorphous systems.

摘要

无定形药物递送系统因其能够提高水溶性差的药物的溶解度、溶解率和生物利用度而受到越来越多的关注。然而,结晶风险是其应用的主要限制因素之一。人们普遍认识到共晶形成剂在共晶制剂的物理稳定性中起着至关重要的作用。不幸的是,最佳共晶形成剂的筛选仍然采用试错法,既耗时又昂贵。在此,我们利用基于官能团之间相互作用的超分子合成子方法,设计了由盐酸鲁拉西酮(LH)和三种共晶形成剂(糖精(SAC)、L-色氨酸(TRP)和 L-半胱氨酸盐酸盐(CYS))组成的无定形系统(CMs)。X 射线粉末衍射表明,无定形系统的物理稳定性顺序为 LH-CYS CM > LH-TRP CM > LH-SAC CM。红外光谱和固态 C NMR 证实了 LH 与共晶形成剂之间的电荷辅助氢键。此外,通过理论计算(包括混溶性计算、分子动力学模拟和量子化学计算)定量了结构、电子和分子相互作用信息,特别是氢键相互作用。结果表明,LH-CYS CM 表现出最佳的混溶性、最强的结合能和部分共价特征的最强氢键,表明超分子合成子在稳定无定形制剂中起着重要作用。有趣的是,在三种无定形系统中,LH-TRP CM 表现出最低的分子迁移率,而不是 LH-CYS CM,这与它们的物理稳定性不一致。但从热力学角度来看,无定形系统的构象熵和物理稳定性的顺序完全一致。我们揭示了分子迁移率和构象熵对无定形系统物理稳定性的综合影响。重要的是,本文还讨论了超分子合成子与动力学/热力学机制之间的关系,并提出了构象熵与分子间相互作用之间的正相关关系。我们的研究结果表明,超分子合成子在设计具有定制物理稳定性的无定形系统方面具有巨大潜力,并进一步深入了解了无定形系统物理稳定性的机制。

相似文献

1
The potential of supramolecular synthon to develop coamorphous systems with tailored physical stability: Mechanistic insights integrating kinetics and thermodynamics.超分子构筑基元在开发具有定制物理稳定性的共无定形系统方面的潜力:整合动力学和热力学的机制见解。
Int J Pharm. 2024 Dec 25;667(Pt A):124857. doi: 10.1016/j.ijpharm.2024.124857. Epub 2024 Oct 21.
2
Mechanistic insights into the crystallization of coamorphous drug systems.探讨共无定形药物系统结晶的机制见解。
J Control Release. 2023 Feb;354:489-502. doi: 10.1016/j.jconrel.2023.01.019. Epub 2023 Jan 19.
3
Incorporation of Complexation into a Coamorphous System Dramatically Enhances Dissolution and Eliminates Gelation of Amorphous Lurasidone Hydrochloride.将络合作用纳入共无定形系统可显著提高无定形盐酸鲁拉西酮的溶解性能并消除其胶凝作用。
Mol Pharm. 2020 Jan 6;17(1):84-97. doi: 10.1021/acs.molpharmaceut.9b00772. Epub 2019 Dec 16.
4
Influence of the p Value of Cinnamic Acid and -Hydroxycinnamic Acid on the Solubility of a Lurasidone Hydrochloride-Based Coamorphous System.肉桂酸和对羟基肉桂酸的p值对盐酸鲁拉西酮基共无定形体系溶解度的影响。
ACS Omega. 2021 Jan 22;6(4):3106-3119. doi: 10.1021/acsomega.0c05510. eCollection 2021 Feb 2.
5
Coamorphization combined with complexation enhances dissolution of lurasidone hydrochloride and puerarin with synchronized release.共形态物形成与络合作用增强了盐酸鲁拉西酮和葛根素的溶解,并实现了同步释放。
Int J Pharm. 2020 Oct 15;588:119793. doi: 10.1016/j.ijpharm.2020.119793. Epub 2020 Aug 19.
6
Improving the Solubility, Dissolution, and Bioavailability of Ibrutinib by Preparing It in a Coamorphous State With Saccharin.将伊布替尼制备成与糖精共无定形状态以提高其溶解度、溶出度和生物利用度。
J Pharm Sci. 2019 Sep;108(9):3020-3028. doi: 10.1016/j.xphs.2019.04.031. Epub 2019 May 5.
7
Coamorphous repaglinide-saccharin with enhanced dissolution.具有增强溶解性能的考阿摩尔型瑞格列奈-糖精共无定形物。
Int J Pharm. 2013 Jun 25;450(1-2):290-5. doi: 10.1016/j.ijpharm.2013.04.032. Epub 2013 Apr 21.
8
Crystallization kinetics and molecular dynamics of binary coamorphous systems of nimesulide and profen analogs.尼美舒利与普洛昔康类似物二元共无定形系统的结晶动力学和分子动力学。
Int J Pharm. 2021 Dec 15;610:121235. doi: 10.1016/j.ijpharm.2021.121235. Epub 2021 Oct 28.
9
Preparation and Characterization of a Rifampicin Coamorphous Material with Tromethamine Coformer: An Experimental-Theoretical Study.制备并表征利福平共无定形物与三羟甲基氨基甲烷共晶形成剂:实验-理论研究。
Mol Pharm. 2024 Mar 4;21(3):1272-1284. doi: 10.1021/acs.molpharmaceut.3c00947. Epub 2024 Feb 15.
10
Coamorphous Active Pharmaceutical Ingredient-Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability.共无定形活性药物成分-小分子混合物:增强溶解和口服生物利用度的共晶选择考虑因素。
J Pharm Sci. 2018 Jan;107(1):5-17. doi: 10.1016/j.xphs.2017.09.024. Epub 2017 Oct 5.